Abstract Details

Title ONO-4641 (Ceralifimod) Prevents Evoked Potential Deficits in an Animal Model of Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 218

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
Frederic Bernard	No disclosure on file
	No disclosure on file
Ursula Boschert Shafaatian (C/o Serono)	Ursula Boschert has nothing to disclose.
Tammy Dellovade	No disclosure on file
David S. Knopman, MD, F�鶹��ýӳ�� (Mayo Clinic)	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.